BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2016-01-01 to 2016-12-31
Filed
2017-11-10
IRS object ID
201733149349301568
Schema version
2016v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-11-10T10:02:03-06:00ReturnTs
Tax Period End2016-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1901 N GLEBE ROAD SUITE 200AddressLine1Txt
CityARLINGTONCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22203ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2016-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INNOVATION ORGANIZATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlBIOTBusinessNameControlTxt
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonYVETTE WHITE-WIGGINSPersonNm
Person TitleCFO AND SVP, FINANCE & ADMINPersonTitleTxt
Phone2029629200PhoneNum
Signature2017-11-10SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonDAVID TRIMNER CPAPreparerPersonNm
PTINP00444822PTIN
Phone5712279500PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address67.137.57.251IPv4AddressTxt
FieldValueIRS element (for citing)
IP2017-11-10IPDt
IP Tm08:44:50IPTm
IP TimezoneESIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdEB2200476D68FB6EEC1AFAD6F1D2D29456870623AtSubmissionCreationDeviceId
At Submission Filing Device IdD4C9CCF27C82EE891DBBD0A0F5B8A17B08786766AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2016TaxYr
Build TS2017-02-10 21:41:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJAMES C GREENWOODPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$77,004,582GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501cYes (X)Organization501cInd
Website AddressWWW.BIO.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1993FormationYr
Legal Domicile StateDCLegalDomicileStateCd
Activity Or MissionSUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND.ActivityOrMissionDesc
Voting Members Governing Body114VotingMembersGoverningBodyCnt
Voting Members Independent114VotingMembersIndependentCnt
Total Employee210TotalEmployeeCnt
Total Volunteers176TotalVolunteersCnt
Total Gross UBI$411,568TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm-$462NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$0PYContributionsGrantsAmt
CY Contributions Grants$0CYContributionsGrantsAmt
PY Program Service Revenue$59,447,799PYProgramServiceRevenueAmt
CY Program Service Revenue$64,830,661CYProgramServiceRevenueAmt
PY Investment Income$9,300,167PYInvestmentIncomeAmt
CY Investment Income$1,712,696CYInvestmentIncomeAmt
PY Other Revenue$5,776,554PYOtherRevenueAmt
CY Other Revenue$10,372,053CYOtherRevenueAmt
PY Total Revenue$74,524,520PYTotalRevenueAmt
CY Total Revenue$76,915,410CYTotalRevenueAmt
PY Grants And Similar Paid$484,833PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$596,583CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$30,323,673PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$31,655,808CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$36,991,328PYOtherExpensesAmt
CY Other Expenses$47,122,286CYOtherExpensesAmt
PY Total Expenses$67,799,834PYTotalExpensesAmt
CY Total Expenses$79,374,677CYTotalExpensesAmt
PY Revenues Less Expenses$6,724,686PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$2,459,267CYRevenuesLessExpensesAmt
Total Assets BOY$73,452,800TotalAssetsBOYAmt
Total Assets EOY$73,322,307TotalAssetsEOYAmt
Total Liabilities BOY$33,238,643TotalLiabilitiesBOYAmt
Total Liabilities EOY$33,540,196TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$40,214,157NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$39,782,111NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
DescADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2016 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- PROMOTED COMPREHENSIVE REFORM OF THE U.S. TAX CODE TO SPUR INNOVATION AND INVESTMENT IN BIOTECHNOLOGY.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - ADVOCATED FOR THE PASSAGE OF THE 21ST CENTURY CURES ACT - SUCCESSFULLY FINISHED NEGOTIATIONS ON REAUTHORIZING THE PRESCRIPTION DRUG USER FEE ACT TO IMPROVE THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.- SUPPORTED THE SEC SMALL BUSINESS ADVOCATE ACT TO ENHANCE THE ROLE OF SMALL BUSINESSES IN THE SEC'S DECISION-MAKING PROCESS, WHICH WAS SIGNED INTO LAW BY PRESIDENT OBAMA IN DECEMBER 2016.THE FOOD & AGRICULTURE SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - SUCCESSFULLY ADVOCATED FOR PASSAGE OF THE NATIONAL BIOENGINEERED FOOD DISCLOSURE LAW - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - WORKED WITH AGRICULTURAL INDUSTRY ALLIES TO OPPOSE FEDERAL AND STATE-LEVEL INITIATIVES AIMED AT MANDATING GMO FOOD LABELING.- ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2016 ADVOCACY ACCOMPLISHMENTS: - PRODUCED A RENEWABLE CHEMICALS REPORT TO CAPTURE THE BROAD SCOPE OF TECHNOLOGIES, PARTNERSHIPS, AND RAPID GROWTH OF THE RENEWABLE CHEMICALS SECTOR.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE PASSAGE AND IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.- SUCCESSFULLY SECURED POSITIVE CHANGES TO EPA'S FINAL RENEWABLE FUEL STANDARDS (RFS) RULE FOR 2017. - URGED CONGRESS TO EXTEND A SUITE OF CRITICAL ADVANCED BIOFUELS TAX INCENTIVES BEYOND 2016.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
DescSERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS APPROXIMATELY 16,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. IN 2016, THE BIO BUSINESS FORUM ALONE HELPED HOST A RECORD NUMBER OF OVER 35,700 PARTNERING MEETINGS AMONG MORE THAN 3,400 COMPANIES, ALONG WITH 192 COMPANY PRESENTATIONS, OVER 800 SPEAKERS, 1,800 EXHIBITIONS WITH 50 INTERNATIONAL, REGIONAL AND STATE PAVILIONS AND SEVEN PRODUCT FOCUS ZONES.BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.Desc
FieldValueIRS element (for citing)
Described In Section501c30DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Subject To Proxy TaxYes (1)SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (1)BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document157IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee210EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryINForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members114GoverningBodyVotingMembersCnt
Independent Voting Member114IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonYVETTE WHITE-WIGGINSPersonNm
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW SUITE 990AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20024ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (171 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
RON COHEN MD
CHAIRMAN2.00Yes (X)Yes (X)$0$0$0
DAVID P MEEKER MD
SECRETARY2.00Yes (X)Yes (X)$0$0$0
BRADFORD A ZAKES
TREASURER2.00Yes (X)Yes (X)$0$0$0
DANIEL JUNIUS
TREASURER (PARTIAL YEAR)2.00Yes (X)Yes (X)$0$0$0
DEBORAH DUNSIRE MD
SECRETARY (PARTIAL YEAR)2.00Yes (X)Yes (X)$0$0$0
ADAM MONROE
BOARD MEMBER2.00Yes (X)$0$0$0
ADELENE PERKINS
BOARD MEMBER2.00Yes (X)$0$0$0
ALAN SHAW
BOARD MEMBER2.00Yes (X)$0$0$0
ALBERT BOURLA
BOARD MEMBER2.00Yes (X)$0$0$0
ALEX AZAR
BOARD MEMBER2.00Yes (X)$0$0$0
ALLEN WAXMAN
BOARD MEMBER2.00Yes (X)$0$0$0
ANNA RATH
BOARD MEMBER2.00Yes (X)$0$0$0
BRIAN BARKER
BOARD MEMBER2.00Yes (X)$0$0$0
C DAVID NICHOLSON
BOARD MEMBER2.00Yes (X)$0$0$0
CARLOS PAYA
BOARD MEMBER2.00Yes (X)$0$0$0
CHRISTIAN NOLET
BOARD MEMBER2.00Yes (X)$0$0$0
CHRISTOPHER BOERNER
BOARD MEMBER2.00Yes (X)$0$0$0
CLIVE MEANWELL
BOARD MEMBER2.00Yes (X)$0$0$0
DAN MEAGHER
BOARD MEMBER2.00Yes (X)$0$0$0
DAPHNE PREUSS
BOARD MEMBER2.00Yes (X)$0$0$0
DAVID MAIN
BOARD MEMBER2.00Yes (X)$0$0$0
DAVID STACK
BOARD MEMBER2.00Yes (X)$0$0$0
DOUG BERVEN
BOARD MEMBER2.00Yes (X)$0$0$0
DOUGLAS DOERFLER
BOARD MEMBER2.00Yes (X)$0$0$0
EDDIE SULLIVAN
BOARD MEMBER2.00Yes (X)$0$0$0
ELI BEN-SHOSHAN
BOARD MEMBER2.00Yes (X)$0$0$0
ELIZABETH LEWIS
BOARD MEMBER2.00Yes (X)$0$0$0
EMIL KAKKIS
BOARD MEMBER2.00Yes (X)$0$0$0
FRANK TERHORST
BOARD MEMBER2.00Yes (X)$0$0$0
GARY PHILLIPS
BOARD MEMBER2.00Yes (X)$0$0$0
GARY ZIEZIULA
BOARD MEMBER2.00Yes (X)$0$0$0
GIL VAN BOKKELEN PHD
BOARD MEMBER2.00Yes (X)$0$0$0
GLENN GORMLEY
BOARD MEMBER2.00Yes (X)$0$0$0
HAROLD E VAN WART PHD
BOARD MEMBER2.00Yes (X)$0$0$0
HENRI A TERMEER
BOARD MEMBER2.00Yes (X)$0$0$0
HERVE HOPPENOT
BOARD MEMBER2.00Yes (X)$0$0$0
HOWARD ROBIN
BOARD MEMBER2.00Yes (X)$0$0$0
HUGH C WELSH JD
BOARD MEMBER2.00Yes (X)$0$0$0
IAN CLARK
BOARD MEMBER2.00Yes (X)$0$0$0
JACK BERNENS
BOARD MEMBER2.00Yes (X)$0$0$0
JAMES HEALY
BOARD MEMBER2.00Yes (X)$0$0$0
JAMES LEVINE
BOARD MEMBER2.00Yes (X)$0$0$0
JAMES SAPIRSTEIN
BOARD MEMBER2.00Yes (X)$0$0$0
JAMES SULLIVAN
BOARD MEMBER2.00Yes (X)$0$0$0
JAY SIEGEL
BOARD MEMBER2.00Yes (X)$0$0$0
JEAN-CHRISTOPHE TELLIER
BOARD MEMBER2.00Yes (X)$0$0$0
JEAN-CHRISTOPHE WESTPHAL
BOARD MEMBER2.00Yes (X)$0$0$0
JEAN-FRANCOIS FORMELA
BOARD MEMBER2.00Yes (X)$0$0$0
JEAN-JACQUES BIENAIME
BOARD MEMBER2.00Yes (X)$0$0$0
JEFFREY CLELAND
BOARD MEMBER2.00Yes (X)$0$0$0
JENNIFER HOLMGREN
BOARD MEMBER2.00Yes (X)$0$0$0
JEREMY LEVIN
BOARD MEMBER2.00Yes (X)$0$0$0
JERRY FLINT
BOARD MEMBER2.00Yes (X)$0$0$0
JIM MEYERS
BOARD MEMBER2.00Yes (X)$0$0$0
JOEL MARCUS
BOARD MEMBER2.00Yes (X)$0$0$0
JOHN CROWLEY
BOARD MEMBER2.00Yes (X)$0$0$0
JOHN GLASSPOOL
BOARD MEMBER2.00Yes (X)$0$0$0
JOHN MARAGANORE
BOARD MEMBER2.00Yes (X)$0$0$0
JOHN MELO
BOARD MEMBER2.00Yes (X)$0$0$0
JOHN MENDLEIN
BOARD MEMBER2.00Yes (X)$0$0$0
JOHN ORWIN
BOARD MEMBER2.00Yes (X)$0$0$0
JOHN SWART
BOARD MEMBER2.00Yes (X)$0$0$0
JONATHAN LEFF
BOARD MEMBER2.00Yes (X)$0$0$0
JONATHAN WOLFSON
BOARD MEMBER2.00Yes (X)$0$0$0
JOSEPH LAROSA
BOARD MEMBER2.00Yes (X)$0$0$0
JOSEPH SHAULSON
BOARD MEMBER2.00Yes (X)$0$0$0
JULIE GERBERDING
BOARD MEMBER2.00Yes (X)$0$0$0
KATHLEEN TREGONING
BOARD MEMBER2.00Yes (X)$0$0$0
KATRINE BOSLEY
BOARD MEMBER2.00Yes (X)$0$0$0
KIRAN MAZUMDAR-SHAW
BOARD MEMBER2.00Yes (X)$0$0$0
MARK ALLES
BOARD MEMBER2.00Yes (X)$0$0$0
MARK ENYEDY
BOARD MEMBER2.00Yes (X)$0$0$0
MARK JONES
BOARD MEMBER2.00Yes (X)$0$0$0
MARK PRUZANSKI
BOARD MEMBER2.00Yes (X)$0$0$0
MARK SKALETSKY
BOARD MEMBER2.00Yes (X)$0$0$0
MARK TIMNEY
BOARD MEMBER2.00Yes (X)$0$0$0
MARKUS POMPEJUS
BOARD MEMBER2.00Yes (X)$0$0$0
MARTIN BABLER
BOARD MEMBER2.00Yes (X)$0$0$0
MAXINE GOWEN
BOARD MEMBER2.00Yes (X)$0$0$0
MICHAEL KNUTZEN
BOARD MEMBER2.00Yes (X)$0$0$0
MICHAEL NARACHI
BOARD MEMBER2.00Yes (X)$0$0$0
MICHAEL RAAB
BOARD MEMBER2.00Yes (X)$0$0$0
MICHELLE DIPP
BOARD MEMBER2.00Yes (X)$0$0$0
MONCEF SLAOUI
BOARD MEMBER2.00Yes (X)$0$0$0
NANCY SIMONIAN
BOARD MEMBER2.00Yes (X)$0$0$0
NEIL GOLDSMITH
BOARD MEMBER2.00Yes (X)$0$0$0
NEIL K WARMA
BOARD MEMBER2.00Yes (X)$0$0$0
NICK LESCHLY
BOARD MEMBER2.00Yes (X)$0$0$0
PAUL EISENBERG
BOARD MEMBER2.00Yes (X)$0$0$0
PAUL HASTINGS
BOARD MEMBER2.00Yes (X)$0$0$0
PERRY KARSEN
BOARD MEMBER2.00Yes (X)$0$0$0
PETER GREENLEAF
BOARD MEMBER2.00Yes (X)$0$0$0
PHILIP MILLER
BOARD MEMBER2.00Yes (X)$0$0$0
PAUL BACKMAN
BOARD MEMBER2.00Yes (X)$0$0$0
RACHEL KING
BOARD MEMBER2.00Yes (X)$0$0$0
RICHARD POPS
BOARD MEMBER2.00Yes (X)$0$0$0
RICK VAN GENDEREN
BOARD MEMBER2.00Yes (X)$0$0$0
RICK WINNINGHAM
BOARD MEMBER2.00Yes (X)$0$0$0
ROBERT REPELLA
BOARD MEMBER2.00Yes (X)$0$0$0
ROBERT WILLS
BOARD MEMBER2.00Yes (X)$0$0$0
RONALD STOTISH
BOARD MEMBER2.00Yes (X)$0$0$0
RUSSELL HERNDON
BOARD MEMBER2.00Yes (X)$0$0$0
SANDY MACRAE
BOARD MEMBER2.00Yes (X)$0$0$0
SABINE LUIK
BOARD MEMBER2.00Yes (X)$0$0$0
SCOTT HOLMSTROM
BOARD MEMBER2.00Yes (X)$0$0$0
SCOTT KOENIG
BOARD MEMBER2.00Yes (X)$0$0$0
STEVEN MENTO
BOARD MEMBER2.00Yes (X)$0$0$0
STEVEN PAUL
BOARD MEMBER2.00Yes (X)$0$0$0
STUART A ARBUCKLE
BOARD MEMBER2.00Yes (X)$0$0$0
THOMAS MATHERS
BOARD MEMBER2.00Yes (X)$0$0$0
THOMAS WIGGANS
BOARD MEMBER2.00Yes (X)$0$0$0
TIMOTHY P WALBERT
BOARD MEMBER2.00Yes (X)$0$0$0
TJERK DE RUITER
BOARD MEMBER2.00Yes (X)$0$0$0
WILLIAM FIZSIMMONS
BOARD MEMBER2.00Yes (X)$0$0$0
WILLIAM HINSHAW
BOARD MEMBER2.00Yes (X)$0$0$0
WILLIAM NEWELL
BOARD MEMBER2.00Yes (X)$0$0$0
ADRIAN ADAMS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
ARLENE MORRIS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
BILL LIS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
BRADLEY A SHURDUT ESQ
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
CENAN OZMERAL
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
CHRISTI L SHAW
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
CHRISTOPHER STANDLEE
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
DANIEL APEL
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
DANIEL CUMMINGS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
DANIEL TASSE
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
DAVID HALLAL
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
DAVID PYOTT
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
DAVID SCHENKEIN MD
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
EDWARD WILLIAMS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
FAHEEM HASNAIN
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
FLEMING ORNSKOV
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
GENO GERMANO
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
H THOMAS WATKINS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
HABIB DABLE
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
HANS SCHIKAN
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
JEFFREY HANKE
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
JEFFREY HATFIELD
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
JEFFREY WREN
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
JOHN MILLIGAN
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
JOSEF APPEL
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
KLEANTHIS XANTHOPOULOUS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
KRISTINE PETERSON
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
MARC BEER
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
MARC VERBRUGGEN PHD
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
MATTHIAS MEDER
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
MICHAEL SEVERINO MD
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
PARIS PANAYIOTOPOULOS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
PATRICK GRUBER
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
PAUL HUDSON
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
PONSI TRIVISVAVET
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
RAYMOND SACCHETTI
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
ROBERT KISS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
ROBIN READNOUR
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
ROGER WYSE
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
STANLEY T CROOKE
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
STEPHAN B TANDA
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
STEVEN H HOLTZMAN
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
WILLIAM FEEHERY
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
WILLIAM LIS
BOARD MEMBER (PARTIAL YEAR)2.00Yes (X)$0$0$0
JAMES GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER40.00Yes (X)$2,167,665$0$679,191
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER40.00Yes (X)$285,042$0$61,304
A SCOTT WHITAKER
COO (PARTIAL YEAR)40.00Yes (X)$378,365$0$6,100
THOMAS DILENGE
PRESIDENT, ADVOCACY, LAW & PUBLIC POLICY DIV40.00$604,209$0$64,621Yes (X)
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BUS OPER DIVISION40.00$548,530$0$60,802Yes (X)
AMY FINAN
SVP, BUSINESS DEV (PARTIAL YEAR)40.00$221,285$0$5,499Yes (X)
KATHLEEN HOLCOMBE
SVP, SCIENCE POLICY40.00$425,151$0$34,286Yes (X)
DANIEL DURHAM
EVP, HEALTH POLICY40.00$457,292$0$48,380Yes (X)
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT40.00$508,453$0$50,536Yes (X)
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS40.00$469,065$0$65,176Yes (X)
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY40.00$410,493$0$46,146Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$6,475,550TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$1,122,041TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K88IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
WHITE64
8603 WESTWOOD CENTER DRIVE 4TH FLOTYSONSVA22182COMMUNICATION SERVICES$3,637,817
FREEMAN EXPOSITIONS
PO BOX 660613DALLASTX75266CONVENTION & CONFERENCES GENERAL CONTRAC$2,429,567
SMG FOOD & BEVERAGE
300 CONSHOHOCHEN STATE ROADWEST CONSHOSHOCHENPA19428CATERING$1,778,324
PROJECTION INC
PO BOX 890472CHARLOTTENC28289AV$987,425
MCCALL & ASSOC EVENTS MANAGEMENT INC
350 FLORIDA STREETSAN FRANCISCOCA94110EVENT MANAGEMENT$872,995
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K94CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp (4 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
CONFERENCE/MEETING REVENUE541800$36,266,250$35,903,378$362,872
MEMBERSHIP DUES900099$27,980,251$27,980,251
INTERNATIONAL EFFORTS900099$321,119$321,119
ALLIANCE/OUTREACH SUPPORT900099$263,041$263,041
FieldValueIRS element (for citing)
Total Program Service Revenue$64,830,661TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,712,494TotalRevenueColumnAmt
Exclusion$1,712,494ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$8,671,027TotalRevenueColumnAmt
Exclusion$8,671,027ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$36,959RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$36,959RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$52,415SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$52,213SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$202SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$202TotalRevenueColumnAmt
Exclusion$202ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
LEGAL900099$648,068$648,068
EPF MEMBER SUPPORT900099$500,000$500,000
POLICY SUPPORT900099$244,000$244,000

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$308,958TotalRevenueColumnAmt
Related Or Exempt Func Income$150,000RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$48,696UnrelatedBusinessRevenueAmt
Exclusion$110,262ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$1,701,026OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$76,915,410TotalRevenueColumnAmt
Related Or Exempt Func Income$66,009,857RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$411,568UnrelatedBusinessRevenueAmt
Exclusion$10,493,985ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$596,583TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$5,082,613TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$21,261,323TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$1,168,393TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$2,813,420TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,330,059TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$1,043,520TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$67,104TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$2,699,234TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$57,103TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$12,324,820TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$320,067TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$858,339TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,434,956TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$4,119,901TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,537,522TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$16,599,092TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$5,308TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$3,198,613TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$691,793TotalAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$135,749TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmt
DUES & SUBSCRIPTIONS$1,107,420
OUTREACH$511,460
BIO LEGISLATIVE DAY/FLY$190,343
TAXES PAID$161,239

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$58,703TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$79,374,677TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$61,943BOYAmt
EOY$5,985,669EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$12,937,952BOYAmt
EOY$2,007,963EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$2,130,779BOYAmt
EOY$3,306,569EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$2,095,808BOYAmt
EOY$2,073,003EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$10,206,672LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$8,633,777LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,810,704BOYAmt
EOY$1,572,895EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$54,290,166BOYAmt
EOY$58,032,455EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$125,448BOYAmt
EOY$343,753EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$73,452,800BOYAmt
EOY$73,322,307EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$15,615,548BOYAmt
EOY$17,667,769EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$12,736,910BOYAmt
EOY$11,510,981EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$4,886,185BOYAmt
EOY$4,361,446EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$33,238,643BOYAmt
EOY$33,540,196EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$40,214,157BOYAmt
EOY$39,782,111EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$40,214,157BOYAmt
EOY$39,782,111EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$73,452,800BOYAmt
EOY$73,322,307EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$2,459,267ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$2,027,221NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Substantially All Dues Nonded0SubstantiallyAllDuesNondedInd
Only In House Lobbying0OnlyInHouseLobbyingInd
Agree Carryover Prior YearYes (1)AgreeCarryoverPriorYearInd
Dues Assessments$27,980,251DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY$9,095,951NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov-$428,871NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot$8,667,080NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc$9,233,483AggregateReportedDuesNtcAmt
Taxable-$566,403TaxableAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$6,183,915OtherCostOrOtherBasisAmt
Depreciation$5,124,316DepreciationAmt
Book Value$1,059,599BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$788,262OtherCostOrOtherBasisAmt
Depreciation$736,242DepreciationAmt
Book Value$52,020BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,234,495OtherCostOrOtherBasisAmt
Depreciation$2,773,219DepreciationAmt
Book Value$461,276BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,572,895TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
CAPITAL LEASE OBLIGATION$54,437
DEFERRED RENT$4,307,009
FieldValueIRS element (for citing)
Total Liability$4,361,446TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$82,510,645TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$2,027,221NetUnrealizedGainsInvstAmt
Other Revenue$3,588,158OtherRevenueAmt
Revenue Not Reported$5,615,379RevenueNotReportedAmt
Revenue Subtotal$76,895,266RevenueSubtotalAmt
Investment Expenses Not Incld$57,103InvestmentExpensesNotIncldAmt
Other Revenues Not Included-$36,959OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$20,144RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$76,915,410TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$82,942,691TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$3,625,117OtherExpensesIncludedAmt
Expenses Not Reported$3,625,117ExpensesNotReportedAmt
Expenses Subtotal$79,317,574ExpensesSubtotalAmt
Investment Expenses Not Incld2$57,103InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$57,103ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$79,374,677TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:FOOD & AG SGR FUND 2,815,701. FOOD & AG LEGAL FUND 81,494. BIOSIMILARS REVENUE 405,963. FGR SPECIAL INITIATIVES REVENUE 285,000.
PART XI, LINE 4B - OTHER ADJUSTMENTS:RENTAL EXPENSES -36,959.
PART XII, LINE 2D - OTHER ADJUSTMENTS:FOOD & AG LEGAL FUND EXPENSES 81,494. BIOSIMILAR EXPENSES 405,963. RENTAL EXPENSES 36,959. FGR SPECIAL INITIATIVE EXPENSES 285,000. FOOD & AG SGR FUND 2,815,701.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,04PROGRAM SERVICESCONFERENCES, ADVOCACY AND EDUCATION$350,737
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM02PROGRAM SERVICESCONFERENCES, ADVOCACY AND EDUCATION$238,389
MIDDLE EAST AND NORTH AFRICA00PROGRAM SERVICESADVOCACY$2,500
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES00PROGRAM SERVICESADVOCACY$47,137
SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR,02PROGRAM SERVICESCONFERENCES, ADVOCACY AND EDUCATION$188,301
SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL,02PROGRAM SERVICESEDUCATION AND ADVOCACY$2,553
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees10SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee0ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee10TotalEmployeeCnt
Subtotal Spent$829,617SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$829,617TotalSpentAmt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (37 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
AIDS INSTITUTE
PO BOX 34043BETHESDAMD208270043030458239501(C)(3)$7,000GENERAL SUPPORT
ALLIANCE FOR AGING RESEARCH
507 CAPITOL COURT NE SUITE 200WASHINGTONDC20002521316086501(C)(3)$15,000GENERAL SUPPORT
ALLIANCE FOR LUPUS RESEARCH
PO BOX 465ENCAMPMENTWY82325830264665501(C)(3)$5,000SPONSORSHIP
ALS ASSOCIATION
1275 K STREET NW SUITE 1050WASHINGTONDC20005133271855501(C)(3)$7,000SPONSORSHIP
AMERICAN CANCER SOCIETY ACTION NETWORK
55 KENOSIA AVENUEDANBURYCT06810133223946501(C)(3)$5,000GENERAL SUPPORT
AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH
1789 MASSACHUSETTS AVENUE NWWASHINGTONDC20036530218495501(C)(3)$25,000GENERAL SUPPORT
AMERICAN FARM BUREAU
750 17TH STREET NW SUITE 110WASHINGTONDC20006541379174501(C)(3)$7,500SPONSORSHIP
AMERICAN HEART ASSOCIATION
515 NORTH MIDLAND AVENUEUPPER NYACKNY10960204039120501(C)(3)$50,000SPONSORSHIP
C-CHANGE
9160 SOUTH 300 WEST 21SANDYUT84070870509416501(C)(3)$15,000GENERAL SUPPORT
CAREGIVER ACTION NETWORK
200 MARYLAND AVENUE NEWASHINGTONDC20002520796820501(C)(3)$5,000SPONSORSHIP
CITIZENS FOR A RESPONSIBLE BOLDER
PO BOX 2371ALEXANDRIAVA22301710874241501(C)(3)$15,000SPONSORSHIP
EPILEPSY FOUNDATION
901 E STREET NW SUITE 405WASHINGTONDC20004311581756501(C)(3)$10,000GENERAL SUPPORT
EVERYLIFE FOUNDATION FOR RARE DISEASES
2000 N BEAUREGARD STREET 6TH FLOORALEXANDRIAVA22311131614906501(C)(3)$10,000SPONSORSHIP
FRIENDS OF CANCER RESEARCH
330 7TH AVENUE SUITE 1701NEW YORKNY10001061565950501(C)(3)$5,000SPONSORSHIP
GALIEN FOUNDATION
99 JOHN STREET SUITE 2502NEW YORKNY10038264549935501(C)(3)$20,000SPONSORSHIP
GLOBAL GENES
PO BOX 791139BALTIMOREMD212791139521694732501(C)(3)$20,833SPONSORSHIP
GROWTH ENERGY
PO BOX 30273OMAHANE68103263542537501(C)(6)$20,000CONTRIBUTION
JDRF INTERNATIONAL
1200 NEW HAMPSHIRE AVENUE NW SUITEWASHINGTONDC20036311750942501(C)(3)$8,750SPONSORSHIP575
LEADERS OF AMERICAN AGRICULTURE
4720 MONTGOMERY LANE SUITE 205BETHESDAMD20814521931357501(C)(3)$5,000SPONSORSHIP
MELANO RESEARCH ALLIANCE FOUNDATION
1101 NEW YORK AVENUE SUITE 620WASHINGTONDC20005261636099501(C)(3)$10,000SPONSORSHIP
MICHAEL J FOX FOUNDATION
52 VANDERBILT AVENUENEW YORKNY10017132912529501(C)(3)$5,000GENERAL SUPPORT
NAT'L ORG FOR RARE DISORDERS
1025 VERMONT AVENUE SUITE 1120WASHINGTONDC20005943172675501(C)(3)$5,000SPONSORSHIP
NATIONAL ALLIANCE OF STATE AND TERRITORIAL
5845 RICHMOND HIGHWAY SUITE 800ALEXANDRIAVA22303135644916501(C)(3)$10,000GENERAL SUPPORT
NATIONAL ALLIANCE ON MENTAL ILLNESS
750 FIRST STREET NW 7TH FLOORWASHINGTONDC20002113485631501(C)(3)$5,000GENERAL SUPPORT
NATIONAL FARMERS UNION
4699 MURPHY CANYON ROADSAN DIEGOCA92123952644377501(C)(3)$10,000SPONSORSHIP
NATIONAL HEALTH COUNCIL
1730 M STREET NW SUITE 500WASHINGTONDC200364561131624107501(C)(3)$25,000SPONSORSHIP
NATIONAL OILSEED PROCESSORS
5005 LBJ TEXAS FREEWAY SUITE 250DALLASTX75244751835298501(C)(3)$7,500SPONSORSHIP
PARENT PROJECT MUSCULAR DYSTROPHY
101 YGNACIO VALLEY ROAD SUITE 110WALNUT CREEKCA94596131788491501(C)(3)$20,000SPONSORSHIP
PARKINSON'S ACTION NETWORK
1025 VERMONT AVENUE SUITE 1120WASHINGTONDC20005943172675501(C)(3)$7,000SPONSORSHIP
PREVENT CANCER FOUNDATION
1600 DUKE STREET SUITE 500ALEXANDRIAVA22314521429544501(C)(3)$5,000SPONSORSHIP
REAGAN-UDALL FOUNDATION FOR FDA
1025 CONNECTICUT AVENUE NW SUITEWASHINGTONDC20036263727917501(C)(3)$5,000SPONSORSHIP1000
RETIRESAFE
1101 NEW YORK AVENUE SUITE 620WASHINGTONDC20006261636099501(C)(3)$5,000SPONSORSHIP
SOCIETY FOR WOMENS HEALTH
1600 DUKE STREET SUITE 500ALEXANDRIAVA22314521429544501(C)(3)$15,000SPONSORSHIP
THE CONGRESSIONAL HUNGER CENTER
701 SW 27TH AVENUE SUITE 705MIAMIFL33135592767754501(C)(3)$10,000SPONSORSHIP
THE MILKEN INSTITUTE
750 9TH STREET NW SUITE 750WASHINGTONDC20001264614274501(C)(3)$25,000GENERAL SUPPORT
US CHAMBER OF COMMERCE
1101 K STREET SUITE 610WASHINGTONDC20005530045720501(C)(3)$166,000MEMBERSHIP AND GENERAL SUPPORT
UTAH FAMILIES FOUNDATION
678 EAST VINE STREETMURRAYUT84107870509416501(C)(3)$5,000SPONSORSHIP
FieldValueIRS element (for citing)
Total501c3 Org36Total501c3OrgCnt
Total Other Org1TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationBIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Travel For CompanionsYes (X)TravelForCompanionsInd
Discretionary Spending AcctYes (X)DiscretionarySpendingAcctInd
Written Policy Ref T And E Expnss0WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (1)SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
JAMES GREENWOOD
PRESIDENT & CHIEF EXECUTIVE OFFICER$1,345,294$0$778,371$0$44,000$0$608,411$0$70,780$0$2,846,856$0$0$0
YVETTE WHITE-WIGGINS
SVP & CHIEF FINANCIAL OFFICER$255,042$0$30,000$0$0$0$32,319$0$28,985$0$346,346$0$0$0
A SCOTT WHITAKER
COO (PARTIAL YEAR)$130,153$0$214,570$0$33,642$0$0$0$6,100$0$384,465$0$0$0
THOMAS DILENGE
PRESIDENT, ADVOCACY, LAW & PUBLIC PO$455,803$0$148,406$0$0$0$35,000$0$29,621$0$668,830$0$0$0
JOANNE DUNCAN
PRESIDENT, MEMBERSHIP & BUS OPER DIV$431,966$0$116,564$0$0$0$35,000$0$25,802$0$609,332$0$0$0
AMY FINAN
SVP, BUSINESS DEV (PARTIAL YEAR)$95,475$0$111,316$0$14,494$0$2,492$0$3,007$0$226,784$0$0$0
KATHLEEN HOLCOMBE
SVP, SCIENCE POLICY$320,779$0$104,372$0$0$0$32,426$0$1,860$0$459,437$0$0$0
DANIEL DURHAM
EVP, HEALTH POLICY$407,292$0$50,000$0$0$0$28,225$0$20,155$0$505,672$0$0$0
BRENT ERICKSON
EVP, INDUSTRIAL & ENVIRONMENT$381,753$0$126,700$0$0$0$35,000$0$15,536$0$558,989$0$0$0
JOSEPH DAMOND
SVP, INTERNATIONAL AFFAIRS$351,542$0$117,523$0$0$0$35,000$0$30,176$0$534,241$0$0$0
ELIZABETH ESHAM
EVP, ECS & VP, SCIENCE & REGULATORY$315,000$0$95,493$0$0$0$35,000$0$11,146$0$456,639$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1AJAMES GREENWOOD: - NOT INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - FIRST CLASS OR CHARTER TRAVEL - $20,334 - INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - TRAVEL FOR COMPANIONS - $7,020
PART I, LINE 1BTHE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES.
PART I, LINE 4BJAMES GREENWOOD - 457(F) $573,411

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

FieldValueIRS element (for citing)
PersonLAURA GREENWOODPersonNm
FieldValueIRS element (for citing)
Relationship DescriptionDAUGHTER OF CEORelationshipDescriptionTxt
Transaction$59,060TransactionAmt
TransactionPAID EMPLOYEE OF ORGANIZATIONTransactionDesc
Sharing Of Revenues0SharingOfRevenuesInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 4THE BIOTECHNOLOGY INDUSTRY ORGANIZATION OFFICIALLY CHANGED ITS NAME TO THE BIOTECHNOLOGY INNOVATION ORGANIZATION ON JANUARY 5, 2016. AS A RESULT, THE BYLAWS FOR THE FULL BIO BOARD OF DIRECTORS AND THE FOUR BIO SECTIONS MUST BE AMENDED TO REFLECT THAT CHANGE. THE BYLAWS AMENDMENTS WERE PRESENTED AND FORMALLY APPROVED BY THE BIO GOVERNANCE & COMPLIANCE COMMITTEE AT ITS MEETING ON MAY 9, 2016. REVISION OF BYLAWS WAS ISSUED ON JUNE 6, 2016.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AAT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, DIVISION PRESIDENTS, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15FOR 2016, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2016, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER AND THE ACTING CHIEF OPERATING OFFICER LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART IX, LINE 11GEC EMERGING PRIORITIES 8,709,179. CONSULTANTS AND OTHER PROFESSIONAL FEES 2,371,728. WORKPLAN OBJECTIVES 358,994. ECONOMIC STUDIES 252,345. RECRUITMENT 179,801. TEMPORARY HELP 141,470. PROGRAM INITIATIVES 84,770. BUSINESS STRATEGIES 78,312. EDUCATION 62,036. INTERNS 34,755. BIO-PAC ADMINISTRATIVE 28,948. I&E INITIATIVES 13,592. I&E FOCUS GROUPS 5,000. CEO DELEGATION EXPENSE 3,890.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.